Latest Intelligence on Pharmaceuticals and Healthcare

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Handheldmed.com: targeting physicians of the future

Published By Datamonitor
11 Sep 2000
CommentWire
CommentWire

HGS: good news for genomics companies

Published By Datamonitor
14 Sep 2000
CommentWire
CommentWire

BMS fails to fight off generic competition for Taxol

Published By Datamonitor
15 Sep 2000
Expert View
Expert View

The monoclonal model of drug development

Published By Datamonitor
15 Sep 2000
CommentWire
CommentWire

Johnson and Johnson: seizing the handheld marketing opportunity

Published By Datamonitor
18 Sep 2000
CommentWire
CommentWire

Antisoma: rollercoaster ride

Published By Datamonitor
19 Sep 2000
CommentWire
CommentWire

Bayer: rethinking pricing strategies

Published By Datamonitor
19 Sep 2000
CommentWire
CommentWire

Eli Lilly: cheeky but risky insulin strategy

Published By Datamonitor
19 Sep 2000
CommentWire
CommentWire

AstraZeneca: hearty results for Zestril

Published By Datamonitor
21 Sep 2000
Expert View
Expert View

Waste not, want not: drug delivery to the rescue

Published By Datamonitor
22 Sep 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.